A Netherton syndrome case report: Response to dupilumab treatment

Dermatol Ther. 2022 Nov;35(11):e15862. doi: 10.1111/dth.15862. Epub 2022 Oct 6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Netherton Syndrome* / diagnosis
  • Netherton Syndrome* / drug therapy

Substances

  • dupilumab
  • Antibodies, Monoclonal, Humanized